China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHIFree Report) in a research report released on Tuesday morning. The firm issued a hold rating on the stock.

China Pharma Stock Performance

Shares of China Pharma stock opened at $0.19 on Tuesday. The company’s 50 day moving average price is $0.21 and its 200-day moving average price is $0.22. China Pharma has a 52-week low of $0.13 and a 52-week high of $0.69. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.26 and a current ratio of 0.79.

About China Pharma

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Further Reading

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.